Productive center with more capacidades de formas farmacéuticas in Central America
The NovoSwiss Pharmaceuticals manufacturing plant in Guatemala is consolidating its position as the pharmaceutical production center with greater diversity and capacity of pharmaceutical dosage forms in Central America, integrating production, regional distribution and new product development under the most high international quality standards.
It features multiple manufacturing lines that cover a wide variety of pharmaceutical forms, including:
The pilot plant integrates advanced pharmaceutical research and development capabilities, featuring:
product developments
new ones per year
annual releases
pharmaceutical forms
active
Conducting Bioequivalence Studies
It has specialized analytical infrastructure, including high-performance liquid chromatography (HPLC), dissolution testers, stability testing chambers, and a highly qualified technical team, supported by ongoing investment in technology and infrastructure.
In addition, our NovoSwiss production facility has a specialized product packaging center.
Overall, the NovoSwiss plant in Guatemala is a regional leader in pharmaceutical manufacturing, standing out for its wide range of dosage forms, production scale, capacity for innovation, and compliance with international regulations, positioning it as the manufacturing facility with the broadest range of dosage forms in Central America.
The manufacturing plant located in Guatemala operates under strict quality standards and regulatory compliance, holding certification from the Ministry of Public Health and Social Assistance (MSPAS) of Guatemala, as well as the backing of World Health Organization (WHO) Technical Report Series No. 32. The facility complies with Good Manufacturing Practices (GMP), ensuring controlled processes, traceability, and quality assurance at every stage of production.
The plant is specialized in the manufacturing of various pharmaceutical dosage forms, including aerosols, solids (tablets and capsules), semi-solids (creams, gels, and ointments), and powders for suspension. Its production areas are designed with technology and environmental control systems that ensure product integrity, complying with international and local regulations.
Thanks to its modern infrastructure, qualified personnel, and regulatory compliance, the plant is positioned as a reliable center for pharmaceutical manufacturing in the region.
